Shared on19 Aug 25Fair value Decreased 24%
The downward revision in Milestone Scientific’s price target reflects materially lower revenue growth expectations, leading to a drop in projected fair value from $2.12 to $1.62. What's in the News Eric C.
Shared on24 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Increased 5.03%
AnalystConsensusTarget has increased revenue growth from 18.6% to 22.6%.
Shared on09 Apr 25Fair value Decreased 6.35%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.